Хепатитис Ц (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Хепатитис Ц" in Serbian language version.

refsWebsite

Global rank Serbian rank

40nih.gov

4^th place

8^th place

19doi.org

2^nd place

4^th place

8archive.org

6^th place

5^th place

6web.archive.org

1^st place

5google.ca

838^th place

391^st place

3cdc.gov

218^th place

138^th place

2who.int

195^th place

154^th place

1casemedicine.com

low place

1georgetown.edu

2,318^th place

1,514^th place

1aafp.org

1,916^th place

2,288^th place

1natap.org

low place

1albawaba.com

3,528^th place

low place

1va.gov

4,581^st place

low place

1phac-aspc.gc.ca

low place

aafp.org

Wilkins, T (1. 6. 2010). Malcolm, JK, Raina, D, Schade, RR. „Hepatitis C: diagnosis and treatment.”. American family physician. 81 (11): 1351—7. PMID 20521755.

albawaba.com

www1.albawaba.com

„Highest Rates of Hepatitis C Virus Transmission Found in Egypt”. Al Bawaba. 9. 8. 2010. Архивирано из оригинала 15. 05. 2012. г. Приступљено 27. 8. 2010.

archive.org

Ryan KJ, Ray CG, ур. (2004). Sherris Medical Microbiology (4th изд.). McGraw Hill. стр. 551–52. ISBN 978-0-8385-8529-0.
Ryan KJ, Ray CG, ур. (2004). Sherris Medical Microbiology (4th изд.). McGraw Hill. стр. 551-2. ISBN 978-0-8385-8529-0.
Xia, X (2008). Luo, J, Bai, J, Yu, R.. „Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis.”. Public health. 122 (10): 990—1003. PMID 18486955. doi:10.1016/j.puhe.2008.01.014.
Marx, John (2010). Rosen's emergency medicine: concepts and clinical practice 7th edition. Philadelphia, PA: Mosby/Elsevier. стр. 1154. ISBN 9780323054720.
Senadhi, V (2011). „A paradigm shift in the outpatient approach to liver function tests.”. Southern medical journal. 104 (7): 521—5. PMID 21886053.
Foote BS, Spooner LM, Belliveau PP (2011). „Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacother. 45 (9): 1085—93. PMID 21828346. doi:10.1345/aph.1P744.
Smith LS, Nelson M, Naik S, Woten J (2011). „Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacother. 45 (5): 639—48. PMID 21558488. doi:10.1345/aph.1P430.
Liu, J (2003). Manheimer, E, Tsutani, K, Gluud, C.. „Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials.”. The American journal of gastroenterology. 98 (3): 538—44. PMID 12650784.

casemedicine.com

Rosen, HR (23. 6. 2011). „Clinical practice. Chronic hepatitis C infection.” (PDF). The New England journal of medicine. 364 (25): 2429—38. PMID 21696309. Архивирано из оригинала (PDF) 15. 12. 2012. г. Приступљено 10. 1. 2014.

cdc.gov

„Q&A for Health Professionals”. Viral Hepatitis. Centers for Disease Control and Prevention. Приступљено 28. 9. 2020.
„Hepatitis C” (PDF). Center for Disease Control and Prevention. Приступљено 2. 1. 2012.
„Hepatitis C”. FAQ – CDC Viral Hepatitis. Приступљено 2. 1. 2012.

doi.org

Houghton, M (2009). „The long and winding road leading to the identification of the hepatitis C virus”. Journal of Hepatology. 51 (5): 939—48. PMID 19781804. doi:10.1016/j.jhep.2009.08.004.
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989). „Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome”. Science. 244 (4902): 359—62. PMID 2523562. doi:10.1126/science.2523562.
Kuo, G; Choo, QL; Alter, HJ (1989). „An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis”. Science. 244 (4902): 362—4. PMID 2496467. doi:10.1126/science.2496467.
Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M (2011). „An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region”. Liver Int. PMID 22142261. doi:10.1111/j.1478-3231.2011.02684.x.
Xia, X (2008). Luo, J, Bai, J, Yu, R.. „Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis.”. Public health. 122 (10): 990—1003. PMID 18486955. doi:10.1016/j.puhe.2008.01.014.
Nelson, PK (13. 8. 2011). Mathers, BM, Cowie, B, Hagan, H, Des Jarlais, D, Horyniak, D, Degenhardt, L.. „Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.”. Lancet. 378 (9791): 571—83. PMID 21802134. doi:10.1016/S0140-6736(11)61097-0.
Tohme RA, Holmberg SD (2010). „Is sexual contact a major mode of hepatitis C virus transmission?”. Hepatology. 52 (4): 1497—505. PMID 20635398. doi:10.1002/hep.23808.
Lock, G; Dirscherl, M.; Obermeier, F (2006). „Hepatitis C —contamination of toothbrushes: myth or reality?”. J. Viral Hepat. 13 (9): 571—3. PMID 16907842. doi:10.1111/j.1365-2893.2006.00735.x.
Maheshwari, A (26. 7. 2008). Ray, S, Thuluvath, PJ. „Acute hepatitis C.”. Lancet. 372 (9635): 321—32. PMID 18657711. doi:10.1016/S0140-6736(08)61116-2.
Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (2007). „Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach”. Digestive and Liver Disease. 39 (1): 2—17. PMID 16884964. doi:10.1016/j.dld.2006.06.008.
Torresi, J (2011). Johnson, D, Wedemeyer, H.. „Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.”. Journal of hepatology. 54 (6): 1273—85. PMID 21236312. doi:10.1016/j.jhep.2010.09.040.
Foote BS, Spooner LM, Belliveau PP (2011). „Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacother. 45 (9): 1085—93. PMID 21828346. doi:10.1345/aph.1P744.
Smith LS, Nelson M, Naik S, Woten J (2011). „Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacother. 45 (5): 639—48. PMID 21558488. doi:10.1345/aph.1P430.
Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB (2011). „An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases”. Hepatology. 54 (4): 1433—44. PMC 3229841 . PMID 21898493. doi:10.1002/hep.24641.
Alavian SM, Tabatabaei SV (2010). „Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis”. J. Viral Hepat. 17 (4): 236—44. PMID 19638104. doi:10.1111/j.1365-2893.2009.01170.x.
El Khoury, A. C. (1. 12. 2011). Klimack, W. K., Wallace, C., Razavi, H.. „Economic burden of hepatitis C-associated diseases in the United States”. Journal of Viral Hepatitis. doi:10.1111/j.1365-2893.2011.01563.x.
Ahn, J (2011). Flamm, SL. „Hepatitis C therapy: other players in the game”. Clinics in liver disease. 15 (3): 641—56. PMID 21867942. doi:10.1016/j.cld.2011.05.008.
Halliday, J (2011). Klenerman, P, Barnes, E.. „Vaccination for hepatitis C virus: closing in on an evasive target.”. Expert review of vaccines. 10 (5): 659—72. PMID 21604986. doi:10.1586/erv.11.55.
Fung, J; Lai, CL; Hung, I (2008). „Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin”. The Journal of Infectious Diseases. 198 (6): 808—12. PMID 18657036. doi:10.1086/591252.

georgetown.edu

ll.georgetown.edu

Wilken, Judge. „United States Court of Appeals for the Federal Circuit”. United States Court of Appeals for the Federal Circuit. Приступљено 11. 1. 2012.

google.ca

books.google.ca

Boyer, JL (2001). Liver cirrhosis and its development: proceedings of the Falk Symposium 115. Springer. стр. 344. ISBN 9780792387602.
Colacino 2004, стр. 32 Colacino, J. M., ур. (2004). Hepatitis prevention and treatment. Heinz, B. A. Basel: Birkhäuser. стр. 32. ISBN 9783764359560.
Brunette], Gary W. (ур.). CDC health information for international travel : the Yellow Book 2012. New York: Oxford University. стр. 231. ISBN 9780199769018.
Chronic Hepatitis C Virus Advances in Treatment, Promise for the Future. Springer Verlag. 2011. стр. 4. ISBN 9781461411918.
Chronic Hepatitis C Virus Advances in Treatment, Promise for the Future. Springer Verlag. 2011. стр. 103—104. ISBN 9781461411918.

natap.org

Jafari, S (2010). Copes, R, Baharlou, S, Etminan, M, Buxton, J.. „Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis.” (PDF). International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 14 (11): e928—40. PMID 20678951.

nih.gov

ncbi.nlm.nih.gov

Maheshwari, A (2010). Thuluvath, PJ. „Management of acute hepatitis C.”. Clinics in liver disease. 14 (1): 169—76; x. PMID 20123448.
Rosen, HR (23. 6. 2011). „Clinical practice. Chronic hepatitis C infection.” (PDF). The New England journal of medicine. 364 (25): 2429—38. PMID 21696309. Архивирано из оригинала (PDF) 15. 12. 2012. г. Приступљено 10. 1. 2014.
Houghton, M (2009). „The long and winding road leading to the identification of the hepatitis C virus”. Journal of Hepatology. 51 (5): 939—48. PMID 19781804. doi:10.1016/j.jhep.2009.08.004.
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989). „Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome”. Science. 244 (4902): 359—62. PMID 2523562. doi:10.1126/science.2523562.
Kuo, G; Choo, QL; Alter, HJ (1989). „An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis”. Science. 244 (4902): 362—4. PMID 2496467. doi:10.1126/science.2496467.
Alter, MJ (7. 5. 2007). „Epidemiology of hepatitis C virus infection.”. World journal of gastroenterology : WJG. 13 (17): 2436—41. PMID 17552026.
Wilkins, T (1. 6. 2010). Malcolm, JK, Raina, D, Schade, RR. „Hepatitis C: diagnosis and treatment.”. American family physician. 81 (11): 1351—7. PMID 20521755.
Ozaras, R (2009). Tahan, V.. „Acute hepatitis C: prevention and treatment.”. Expert review of anti-infective therapy. 7 (3): 351—61. PMID 19344247.
Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M (2011). „An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region”. Liver Int. PMID 22142261. doi:10.1111/j.1478-3231.2011.02684.x.
Pondé, RA (2011). Mikhaĭlova, A.. „Hidden hazards of HCV transmission.”. Medical microbiology and immunology. 200 (1): 7—11. PMID 20461405.
Xia, X (2008). Luo, J, Bai, J, Yu, R.. „Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis.”. Public health. 122 (10): 990—1003. PMID 18486955. doi:10.1016/j.puhe.2008.01.014.
Nelson, PK (13. 8. 2011). Mathers, BM, Cowie, B, Hagan, H, Des Jarlais, D, Horyniak, D, Degenhardt, L.. „Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.”. Lancet. 378 (9791): 571—83. PMID 21802134. doi:10.1016/S0140-6736(11)61097-0.
Imperial, JC (2010). „Chronic hepatitis C in the state prison system: insights into the problems and possible solutions.”. Expert review of gastroenterology & hepatology. 4 (3): 355—64. PMID 20528122.
Vescio, MF (2008). Longo, B, Babudieri, S, Starnini, G, Carbonara, S, Rezza, G, Monarca, R.. „Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis.”. Journal of epidemiology and community health. 62 (4): 305—13. PMID 18339822.
Jafari, S (2010). Copes, R, Baharlou, S, Etminan, M, Buxton, J.. „Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis.” (PDF). International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 14 (11): e928—40. PMID 20678951.
Tohme RA, Holmberg SD (2010). „Is sexual contact a major mode of hepatitis C virus transmission?”. Hepatology. 52 (4): 1497—505. PMID 20635398. doi:10.1002/hep.23808.
Lock, G; Dirscherl, M.; Obermeier, F (2006). „Hepatitis C —contamination of toothbrushes: myth or reality?”. J. Viral Hepat. 13 (9): 571—3. PMID 16907842. doi:10.1111/j.1365-2893.2006.00735.x.
Lam, NC (15. 11. 2010). Gotsch, PB, Langan, RC. „Caring for pregnant women and newborns with hepatitis B or C.”. American family physician. 82 (10): 1225—9. PMID 21121533.
Mast, EE (2004). „Mother-to-infant hepatitis C virus transmission and breastfeeding”. Advances in Experimental Medicine and Biology. 554: 211—6. PMID 15384578.
Maheshwari, A (26. 7. 2008). Ray, S, Thuluvath, PJ. „Acute hepatitis C.”. Lancet. 372 (9635): 321—32. PMID 18657711. doi:10.1016/S0140-6736(08)61116-2.
Mueller, S (28. 7. 2009). Millonig, G, Seitz, HK. „Alcoholic liver disease and hepatitis C: a frequently underestimated combination.”. World journal of gastroenterology : WJG. 15 (28): 3462—71. PMID 19630099.
Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (2007). „Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach”. Digestive and Liver Disease. 39 (1): 2—17. PMID 16884964. doi:10.1016/j.dld.2006.06.008.
Louie, KS (2011). Micallef, JM, Pimenta, JM, Forssen, UM. „Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review.”. Journal of viral hepatitis. 18 (1): 1—7. PMID 20796208.
Senadhi, V (2011). „A paradigm shift in the outpatient approach to liver function tests.”. Southern medical journal. 104 (7): 521—5. PMID 21886053.
Torresi, J (2011). Johnson, D, Wedemeyer, H.. „Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.”. Journal of hepatology. 54 (6): 1273—85. PMID 21236312. doi:10.1016/j.jhep.2010.09.040.
Ilyas, JA (2011). Vierling, JM. „An overview of emerging therapies for the treatment of chronic hepatitis C.”. Clinics in liver disease. 15 (3): 515—36. PMID 21867934.
Foote BS, Spooner LM, Belliveau PP (2011). „Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacother. 45 (9): 1085—93. PMID 21828346. doi:10.1345/aph.1P744.
Smith LS, Nelson M, Naik S, Woten J (2011). „Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacother. 45 (5): 639—48. PMID 21558488. doi:10.1345/aph.1P430.
Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB (2011). „An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases”. Hepatology. 54 (4): 1433—44. PMC 3229841 . PMID 21898493. doi:10.1002/hep.24641.
Alavian SM, Tabatabaei SV (2010). „Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis”. J. Viral Hepat. 17 (4): 236—44. PMID 19638104. doi:10.1111/j.1365-2893.2009.01170.x.
Liu, J (2003). Manheimer, E, Tsutani, K, Gluud, C.. „Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials.”. The American journal of gastroenterology. 98 (3): 538—44. PMID 12650784.
Rambaldi, A (17. 10. 2007). Jacobs, BP, Gluud, C.. „Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.”. Cochrane database of systematic reviews (Online) (4): CD003620. PMID 17943794.
Ahn, J (2011). Flamm, SL. „Hepatitis C therapy: other players in the game”. Clinics in liver disease. 15 (3): 641—56. PMID 21867942. doi:10.1016/j.cld.2011.05.008.
Vermehren, J (2011). Sarrazin, C.. „New HCV therapies on the horizon.”. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 17 (2): 122—34. PMID 21087349.
Halliday, J (2011). Klenerman, P, Barnes, E.. „Vaccination for hepatitis C virus: closing in on an evasive target.”. Expert review of vaccines. 10 (5): 659—72. PMID 21604986. doi:10.1586/erv.11.55.
Hagan, H (1. 7. 2011). Pouget, ER, Des Jarlais, DC. „A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.”. The Journal of infectious diseases. 204 (1): 74—83. PMID 21628661.
Fung, J; Lai, CL; Hung, I (2008). „Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin”. The Journal of Infectious Diseases. 198 (6): 808—12. PMID 18657036. doi:10.1086/591252.
Eurosurveillance editorial, team (28. 7. 2011). „World Hepatitis Day 2011.”. Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin. 16 (30). PMID 21813077.
Wong, JB (2006). „Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies.”. PharmacoEconomics. 24 (7): 661—72. PMID 16802842.

nccam.nih.gov

Hepatitis C and CAM: What the Science Says Архивирано на сајту Wayback Machine (13. мај 2013). NCCAM March 2011. (Retrieved 07 March 2011)

phac-aspc.gc.ca

„Hepatitis C Prevention, Support and Research ProgramHealth Canada”. Public Health Agency of Canada. 2003. Приступљено 10. 1. 2012.

va.gov

hepatitis.va.gov

„Hepatitis C Group Education Class”. United States Department of Veteran Affairs. Архивирано из оригинала 09. 11. 2011. г. Приступљено 10. 01. 2014.

web.archive.org

„Hepatitis C Fact sheet”. WHO. 24. 6. 2022. Архивирано из оригинала 31. 1. 2016. г. Updated as required.
Rosen, HR (23. 6. 2011). „Clinical practice. Chronic hepatitis C infection.” (PDF). The New England journal of medicine. 364 (25): 2429—38. PMID 21696309. Архивирано из оригинала (PDF) 15. 12. 2012. г. Приступљено 10. 1. 2014.
Winners Albert Lasker Award for Clinical Medical Research, The Lasker Foundation. Приступљено 20 February 2008.
„Highest Rates of Hepatitis C Virus Transmission Found in Egypt”. Al Bawaba. 9. 8. 2010. Архивирано из оригинала 15. 05. 2012. г. Приступљено 27. 8. 2010.
„Hepatitis C Group Education Class”. United States Department of Veteran Affairs. Архивирано из оригинала 09. 11. 2011. г. Приступљено 10. 01. 2014.
Hepatitis C and CAM: What the Science Says Архивирано на сајту Wayback Machine (13. мај 2013). NCCAM March 2011. (Retrieved 07 March 2011)

who.int

„Hepatitis C Fact sheet”. WHO. 24. 6. 2022. Архивирано из оригинала 31. 1. 2016. г. Updated as required.
„WHO Hepatitis C factsheet”. 2011. Приступљено 13. 7. 2011.